IRIS
DE LUCA, Laura
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.890
EU - Europa 6.682
AS - Asia 5.753
SA - Sud America 2.442
AF - Africa 178
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 8
Totale 29.963
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.671
SG - Singapore 2.416
BR - Brasile 2.165
IE - Irlanda 1.738
CN - Cina 1.483
SE - Svezia 1.439
HK - Hong Kong 724
UA - Ucraina 700
IT - Italia 675
DE - Germania 604
VN - Vietnam 456
FI - Finlandia 359
GB - Regno Unito 312
RU - Federazione Russa 285
IN - India 198
FR - Francia 138
AR - Argentina 106
CA - Canada 95
MX - Messico 81
PL - Polonia 79
CZ - Repubblica Ceca 74
BD - Bangladesh 61
BE - Belgio 53
ZA - Sudafrica 51
TR - Turchia 50
IQ - Iraq 49
EC - Ecuador 46
JP - Giappone 46
AT - Austria 43
MA - Marocco 38
UZ - Uzbekistan 37
NL - Olanda 36
ES - Italia 33
ID - Indonesia 29
CO - Colombia 25
CI - Costa d'Avorio 24
PY - Paraguay 21
VE - Venezuela 21
PK - Pakistan 20
KE - Kenya 19
EG - Egitto 17
PE - Perù 17
UY - Uruguay 17
AE - Emirati Arabi Uniti 16
GR - Grecia 15
JO - Giordania 15
AZ - Azerbaigian 14
CL - Cile 14
IR - Iran 14
LV - Lettonia 12
NO - Norvegia 12
NP - Nepal 12
KG - Kirghizistan 11
OM - Oman 11
DO - Repubblica Dominicana 10
KZ - Kazakistan 10
PA - Panama 9
SA - Arabia Saudita 9
BO - Bolivia 8
HN - Honduras 8
LK - Sri Lanka 8
LT - Lituania 8
RO - Romania 8
AL - Albania 7
IL - Israele 7
MY - Malesia 7
PS - Palestinian Territory 7
SK - Slovacchia (Repubblica Slovacca) 7
CH - Svizzera 6
DZ - Algeria 6
RS - Serbia 6
AM - Armenia 5
CR - Costa Rica 5
EE - Estonia 5
MD - Moldavia 5
NZ - Nuova Zelanda 5
PH - Filippine 5
PT - Portogallo 5
XK - ???statistics.table.value.countryCode.XK??? 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AO - Angola 4
KR - Corea 4
LB - Libano 4
SN - Senegal 4
SY - Repubblica araba siriana 4
TN - Tunisia 4
AU - Australia 3
BG - Bulgaria 3
BY - Bielorussia 3
GA - Gabon 3
GE - Georgia 3
GT - Guatemala 3
JM - Giamaica 3
LU - Lussemburgo 3
NG - Nigeria 3
TH - Thailandia 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BN - Brunei Darussalam 2
CG - Congo 2
Totale 29.934
Salva come PNG Salva come JPEG
Città #
Dallas 5.567
Dublin 1.735
Jacksonville 1.326
Chandler 1.321
Singapore 1.119
Ashburn 1.110
Nyköping 945
Hong Kong 722
Beijing 693
Los Angeles 313
Princeton 296
Medford 257
Cambridge 256
Dearborn 256
Des Moines 226
Messina 225
Dong Ket 186
The Dalles 176
Boardman 170
Ann Arbor 158
São Paulo 145
Buffalo 134
Munich 116
Ho Chi Minh City 106
New York 95
Hyderabad 87
Wilmington 82
Woodbridge 79
Moscow 77
Redondo Beach 70
Lancaster 69
Belo Horizonte 64
Pune 59
Warsaw 59
Jinan 58
Turku 57
Brno 56
Tianjin 56
San Mateo 52
Rio de Janeiro 51
Shenyang 51
Brussels 49
Hanoi 49
Brasília 47
Nanjing 45
Brooklyn 42
Council Bluffs 42
Seattle 40
Catania 39
Tokyo 38
Frankfurt am Main 36
London 36
Tashkent 35
Chicago 34
Denver 33
Haikou 33
Lappeenranta 33
Johannesburg 32
Houston 31
Santa Clara 31
Vienna 31
Phoenix 30
Atlanta 29
Hebei 29
Montreal 29
Milan 28
Nuremberg 28
Curitiba 27
Stockholm 27
Taizhou 27
Abidjan 24
Goiânia 24
Hangzhou 24
Orem 23
Rome 23
Campinas 22
Baghdad 21
Chennai 21
Guarulhos 21
Ningbo 21
Washington 21
Düsseldorf 20
Francofonte 20
Helsinki 20
Porto Alegre 20
Boston 19
Guangzhou 19
Mexico City 19
Poplar 19
Toronto 19
Zhengzhou 19
Fuzhou 18
Manchester 18
Fortaleza 17
Ottawa 17
Salvador 17
San Francisco 17
Norwalk 16
Quito 16
Ribeirão Preto 16
Totale 20.281
Salva come PNG Salva come JPEG
Nome #
1,3-diidro-benzimidazoloni analoghi: progettazione, sintesi e SAR di nuovi inibitori non-nucleosidici dell'RT 4.544
1,3-THIAZOLIDIN-4-ONES:POTENT AND HIGHLY SELECTIVE ANTI-HIV-1 AGENTS 223
1,3-Thiazolidin-4-ones: potent and selective anti-HIV-1 agents 216
Chemical exploration of 4-(4-fluorobenzyl)piperidine fragment for the development of new tyrosinase inhibitors 181
1-Benzylpiperidine derivatives: design and synthesis of new compounds as tyrosinase inhibitors from Agaricus bisporus 161
4-Fluorobenzylpiperazine-Containing Derivatives as Efficient Inhibitors of Mushroom Tyrosinase 154
AMPA receptor antagonists: Synthesis and pharmacological evaluation 152
Inhibitory effects and structural insights for a novel series of coumarin-based compounds that selectively target human CA IX and CA XII carbonic anhydrases 148
Anticonvulsant agent: enhancement of physicochemical properties 138
Targeting Tyrosinase: Development and Structural Insights of Novel Inhibitors Bearing Arylpiperidine and Arylpiperazine Fragments 138
4-[1-(4-Fluorobenzyl)-4-hydroxy-1H-indol-3-yl]-2-hydroxy-4-oxobut-2-enoic acid as a prototype to develop dual inhibitors of HIV-1 integration process. 135
Seeking new approach for therapeutic treatment of cholera disease via inhibition of bacterial carbonic anhydrases: experimental and theoretical studies for sixteen benzenesulfonamide derivatives 134
Exploiting the 1-(4-fluorobenzyl)piperazine fragment for the development of novel tyrosinase inhibitors as anti-melanogenic agents: Design, synthesis, structural insights and biological profile 134
Vitamin D: a steroid hormone with progesterone-like activity 133
A New 3D Pharmacophore Model for HIV-1 Integrase Strand Transfer Inhibitors. 132
2-Hydroxyisoquinoline-1,3(2H,4H)-diones as inhibitors of HIV-1 integrase and reverse transcriptase RNase H domain: Influence of the alkylation of position 4 130
Design and optimization of isoquinoline-sulfonamides as potent and selective inhibitors of human carbonic anhydrase VII 129
3D Pharmacophore model and synthesys of NMDA receptor subunit NR2B antagonists 127
A Combination of Pharmacophore and Docking-based Virtual Screening to Discover new Tyrosinase Inhibitors 125
A new potential approach to block HIV-1 replication via protein–protein interaction and strand-transfer inhibition 124
Carbonic anhydrase inhibitors: Design, synthesis and structural characterization of new heteroaryl-N-carbonylbenzenesulfonamides targeting druggable human carbonic anhydrase isoforms 124
A refined pharmacophore model and optimization of 1H-benzylindole HIV-1 integrase inhibitors 123
A New 3D Pharmacophore Model for HIV-1 Integrase Strand Transfer Inhibitors 122
Exploring structural properties of potent human carbonic anhydrase inhibitors bearing a 4-(cycloalkylamino-1-carbonyl)benzenesulfonamide moiety 121
Looking toward the Rim of the Active Site Cavity of Druggable Human Carbonic Anhydrase Isoforms 121
Synthesis, resolution, stereochemistry, and molecular modeling of (R)- and (S)-2-acetyl-1-(4 '-chlorophenyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline AMPAR antagonists 119
Discovery of benzimidazole-based Leishmania mexicana cysteine protease CPB2.8ΔCTE inhibitors as potential therapeutics for leishmaniasis 118
Anti-HIV agents: design and discovery of new potent RT inhibitors 117
A structure-based approach to ligand discovery for inhibition of HIV-1 IN-LEDGF/p75 interaction: a new target for anti-AIDS therapy 117
Graphene Quantum Dots Based Systems As HIV Inhibitors 117
InVivo Evaluation of Selective Carbonic Anhydrase Inhibitors as Potential Anticonvulsant Agents 117
Antiretroviral strategy using multi-target agents 115
Discovery of a new potent inhibitor of mushroom tyrosinase (Agaricus bisporus) containing 4-(4-hydroxyphenyl)piperazin-1-yl moiety 115
Synthesis and biochemical evaluation of 5-(pyridin-4-yl)-4H-1,2,4-triazol-4-amine-based inhibitors of tyrosinase from Agaricus bisporus 114
6-Chloro-1-(3,5-dimethylphenylsulfonyl)-1H-benzimidazol-2(3H)-one 114
DISCOVERY OF NEW INDOLE DERIVATES AS NEUROPROTECTIVE AGENTS 114
In Silico-Guided Identification of New Potent Inhibitors of Carbonic Anhydrases Expressed in Vibrio cholerae 114
Combined strategies for the discovery of ionotropic glutamate receptor antagonists 113
3D Pharmacophore Models for 1,2,3,4-Tetrahydroisoquinoline Derivatives Acting as Anticonvulsant Agents 113
Rational design of small molecules able to inhibit α-synuclein amyloid aggregation for the treatment of Parkinson’s disease 113
4-Sulfamoylphenylalkylamides as Inhibitors of Carbonic Anhydrases Expressed in Vibrio cholerae 113
Binding mode investigation and SAR studies of HIV-1 integrase inhibitors 111
Merging lithium carbenoid homologation and enzymatic reduction: A combinative approach to the HIV-protease inhibitor Nelfinavir 111
Computational methods to analyze and predict the binding mode of inhibitors targeting both human and mushroom tyrosinase 110
Nuovi Antagonisti Non-Competitivi Del Recettore NMDA/NR2b: Design e Sintesi” 110
Modificazioni strutturali del gruppo dichetoacido (DKA) di potenti inibitori dell'Integrasi dell'HIV-1 110
Combined ligand-based and target-based approach to design NR2B/NMDA receptor antagonists 109
Identification of isoquinoline-sulfonamides as potent and selective carbonic anhydrase inhibitors 109
Searching for indole derivatives as potential mushroom tyrosinase inhibitors 109
Synthesis and anti-HIV activity of carboxylated and drug-conjugated multi-walled carbon nanotubes 108
Synthesis and structure-active relationship of 1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline anticonvulsants 108
In Silico Strategy for Targeting the mTOR Kinase at Rapamycin Binding Site by Small Molecules 108
3D pharmacophore model and the synthesis of NMDA receptor subunit NR2B antagonists 107
Nuovi ligandi del recettore NR2B/NMDA a struttura indolica 106
PROGETTAZIONE E SINTESI DI NUOVI DKA ANALOGHI COME POTENZIALI INIBITORI DELL’INTEGRASI DELL’HIV-1 105
Discovery of potent and selective inhibitors of druggable carbonic anhydrase isoforms 105
Small molecules targeting the interaction between HIV-1 integrase and LEDGF/p75 cofactor. 105
HIV-1 integrase strand-transfer inhibitors: Design, synthesis and molecular modeling investigation 105
P158-DEVELOPMENT OF FLEXIBLE ARYLSULFONAMIDES AS POTENTIAL MULTITARGET ANTICANCER AGENTS 105
Inhibitors of the Interactions between HIV-1 IN and the Cofactor LEDGF/p75 104
Evaluation of 4-(4-Fluorobenzyl)piperazin-1-yl]-Based Compounds as Competitive Tyrosinase Inhibitors Endowed with Antimelanogenic Effects 104
Analysis of the full-length integrase-DNA complex by a modified approach for DNA docking 103
Novel Potent Anticonvulsant Agent Containing a Tetrahydroisoquinoline Skeleton. 103
Identification of 3,4-Dihydroisoquinoline-2(1H)-sulfonamides as Potent Carbonic Anhydrase Inhibitors: Synthesis, Biological Evaluation, and Enzyme−Ligand X-ray Studies 103
The 1-(4-fluorobenzyl)piperazine fragment for the development of novel tyrosinase inhibitors 103
Design, synthesis and in vitro evaluation of 4-fluorobenzyl- and 4-hydroxyphenyl-based compounds targeting tyrosinases 103
From 3D-pharmacophore models to synthetic route towards anti-HIV agents 101
Small Molecules Targeting Protein–Protein Interactions: A Promising Anti-HIV Strategy 101
Analysis of structure-activity relationships in a series of 4-(1-piperazinyl)phenol-based derivatives as competitive inhibitors of Tyrosinase 101
Binding modes of noncompetitive AMPA antagonists: a computational approach 100
Design e Sintesi di composti a struttura 3-Indol-Gliossilamidica come potenziali inibitori dell'integrasi dell'HIV-1. 100
Binding mode prediction of Strand Transfer HIV-1 Integrase Inhibitors using Tn5 transposase as a plausible surrogate model for HIV-1 Integrase 100
2-Acetil-1-(4'-clorofenil)-6,7-dimetossi-1,2,3,4-tetraidroisochinolina (Ps3Ac) Potente AMPA-antagonista: Definizione del Profilo Enantiofarmacobiologico 100
Synthesis of new pyridazine derivatives as potential anti-HIV-1 agents 99
New indole derivatives as promising ligands for ifenprodil site of NR2B/NMDA receptors 98
From NMDA receptor antagonists to discovery of selective σ2 receptor ligands 98
Design, synthesis, structure-activity relationships, and molecular modeling studies of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV agents 97
Synthesis and SAR of new 1,3-dihydro-benzimidazolone analogues as non-nucleoside reverse transcriptase inhibitors (NNRTIs) 97
Derivati benzimidazolonici ed analoghi come potenti inibitori non-nucleosidici dell'RT dell'HIV-1 97
Serendipitous discovery of indole derivatives as potent tyrosinase inhibitors 97
Discovery and optimization of isoquinoline-derived inhibitors of human Carbonic Anhydrases (hCAs) 97
Synthesis, biological evaluation and docking studies of NR2B/NMDA receptor antagonists 96
Searching for alpha-syn inhibitors to fight Parkinson’s disease 96
Computational strategies in discovering novel non-nucleoside inhibitors of HIV-1 RT 95
Design, Synthesis and SAR of New Potent HIV-1 RT Inhibitors”. Antiviral Research 95
Simulated human digestion of N1-aryl-2-arylthioacetamidobenzimidazoles and their activity against Herpes-simplex virus 1 in vitro 95
Structural optimization and in vitro evaluation of new 1-(4-fluorobenzyl)piperazine derivatives as inhibitors of Tyrosinase from Agaricus bisporus 95
Structure-activity hypothesis in the design of new AMPA receptor antagonists. 94
Searching for NR2B/NMDA Receptor Antagonists As Neuroprotective Agents 94
Probing the molecular interactions between the human Carbonic Anhydrases (hCAs) and a novel class of benzenesulfonamides 94
INVESTIGATION ON PYRIDINYL-1,2,4-TRIAZOLE-BASED COMPOUNDS AS -SYN AGGREGATION INHIBITORS FOR TREATING PARKINSON’S DISEASE 94
Combined strategies for the discovery of ionotropic glutamate receptor antagonists 93
Insight into the INSTIs binding mode: molecular modeling investigation and SAR studies 93
Exploring the chemical space of 3-chloro-4-fluorophenyl-based compounds as tyrosinase inhibitors 92
Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti- HIV-1 agents 92
Computational Studies to Discover a New NR2B/NMDA Receptor Antagonist and Evaluation of Pharmacological Profile 92
PROGETTAZIONE E SINTESI DI NUOVI DKA ANALOGHI COME POTENZIALI INIBITORI DELL'INTEGRASI DELL'HIV-1 92
Discovery of HIV-1 Integrase and cellular cofactor LEDGF/p75 interaction inhibitors 92
Computational and synthetic approaches for developing Lavendustin B derivatives as allosteric inhibitors of HIV-1 integrase 92
Design and synthesis of 2,3-diaryl-1,3-thiazolidin-4one potent HIV-1 RT-inhibitors. 91
Totale 15.736
Salva come PNG Salva come JPEG
Categoria #
all - tutte 103.978
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 103.978
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.187 0 0 0 0 0 204 19 223 65 238 154 284
2021/20221.844 32 284 33 73 81 29 163 63 39 67 371 609
2022/20235.190 400 443 235 450 387 508 108 273 2.124 15 185 62
2023/20241.327 96 201 96 244 117 221 24 45 5 116 29 133
2024/20255.965 102 95 110 344 257 195 197 1.394 1.462 333 525 951
2025/202610.568 796 2.473 4.282 1.461 1.403 153 0 0 0 0 0 0
Totale 30.357